Company Performance: Tharimmune's financial health, including revenue, earnings, and profitability, directly impacts its stock price. Positive results often lead to price increases.

Clinical Trial Results: As a biotechnology company, the outcomes of Tharimmune's clinical trials for its drug candidates are crucial. Successful trial data can significantly boost investor confidence and the stock price.

Regulatory Approvals: Approval from regulatory bodies like the FDA is a major catalyst. Positive decisions can dramatically increase the stock price, while rejection can cause it to plummet.

Market Sentiment: Overall investor mood regarding the biotechnology sector and the broader market influences Tharimmune's stock. Positive sentiment can drive up the price, while negative sentiment can depress it.

Competition: The presence of competing drugs or therapies in the same therapeutic area can affect Tharimmune's potential market share and thus its stock price.

Partnerships and Acquisitions: Strategic collaborations, licensing agreements, or acquisition news can have a significant impact on the stock price, reflecting the company's growth prospects.

Economic Conditions: Macroeconomic factors such as interest rates, inflation, and overall economic growth can indirectly influence investor behavior and impact the stock price.

News and Events: Industry news, company-specific announcements, and major healthcare events can all affect investor perceptions and drive short-term fluctuations in the stock price.